November 13, 2017 The President & Director, The Stock Exchange of Thailand (SET) LETTER OF CLARIFICTION: CENTEL’s Q3/2017 & YTD 9 MONTHS /2017 OPERATING PERFORMANCE RESULTS This is to inform the SET
compare with the previous year amount to Baht 10.08 million, decrease Baht 0.12 million or decrease 1.17%, this is due to the company set measure to control appropriate spending. 4. Administrative expenses
) was thus equal to 3.32 percent, decreasing over-quarter, but still within the set target of 3.30-3.50 percent. Moreover, other operating expenses rose Baht 21 million or 0.13 percent over-year, due
Page 1 of 4 No. RJH – SET 11/2019 13 August 2019 Subject : Management’s Discussion and Analysis for the 2nd Quarter of 2019 To : The President The Stock Exchange of Thailand Rajthanee Hospital Public
, travelling aboard were not allowed. - The meeting with external parties in person were not allowed, conference call or online meeting was applied instead. - Approving to the change of appropriate working time
, Samutsakhon 74000 No. DOD43/2563 May 14, 2020 To: The President The Stock Exchange of Thailand (SET) Subject: Management’s Discussion and Analysis for the first Quarter of 2020 DOD Biotech Public Company
second quarter ended June 30, 2020 which the details are as follows: Unit: million Baht For 3-month period (Apr-Jun) 2020 2019 Change % Increase (Decrease) Revenue from sale of goods 128.52 164.02 (35.50
November 11, 2020 Subject: Management’s Discussion and Analysis for the third quarter of 2020 To: The President The Stock Exchange of Thailand (SET) DOD Biotech Public Company Limited and its subsidiaries
addition, there is no reasonable ground to believe that the applicant has any deficiency or is not appropriate regarding control and sound business conduct; (3) being able to maintain capital funds and set
; “inside information” means the significant facts which effect the change in the price of securities but has not yet been disclosed to the public and a securities company has acquired during the course of